Inflammatix is a molecular diagnostics company based in Sunnyvale, California, dedicated to enhancing patient care through innovative diagnostic solutions. The company's focus is on accurately interpreting the immune system using advanced computational biology techniques, producing mRNA signatures that assist in the diagnosis, prognosis, and treatment response of acute infections and sepsis. Inflammatix's proprietary tests leverage machine learning algorithms to deliver rapid, precise results at the point of care, empowering healthcare professionals to make informed clinical decisions. The mission is to reduce public health burdens by transforming how acute infections are diagnosed and treated, paving the way for a new era of precision medicine. Inflammatix fosters a culture of collaboration and innovation, attracting talent who are passionate about improving healthcare outcomes and committed to scientific excellence.